Text clustering can streamline many labor-intensive tasks, but it creates a new challenge: efficiently labeling and interpreting the clusters. Generative large language models (LLMs) are a promising option to automate the process of naming text clusters, which could significantly streamline workflows, especially in domains with large datasets and esoteric language. In this study, we assessed the ability of GPT-3.5-turbo to generate names for clusters of texts and compared these to human-generated text cluster names. We clustered two benchmark datasets, each from a specialized domain: research abstracts and clinical patient notes. We generated names for each cluster using four prompting strategies (different ways of including information about the cluster in the prompt used to get LLM responses). For both datasets, the best prompting strategy beat the manual approach across all quality domains. However, name quality varied by prompting strategy and dataset. We conclude that practitioners should consider trying automated cluster naming to avoid bottlenecks or when the scale of the effort is enough to take advantage of the cost savings offered by automation, as detailed in our supplemental blueprint for using LLM cluster naming. However, to get the best performance, it is vital to test a variety of prompting strategies and perform a small test to identify which one performs best on each project’s unique data.
Common data elements to advance ME/CFS research: Standardizing data collection in ME/CFS research through Common Data Elements is a crucial step toward improving diagnosis, advancing treatments, and fostering collaboration across studies to accelerate progress in understanding this complex disease. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a serious, debilitating, and underdiagnosed chronic disease characterized by profound fatigue, unrefreshing sleep, and post-exertional malaise. (1) Despite decades of research, the etiology and pathogenesis of ME/CFS remain unclear. The complexity and heterogeneity of the disorder pose significant challenges for researchers working to identify its underlying mechanisms and develop effective treatments. (1-2) In addition, variability in the diagnostic criteria, assessment methods, and outcome measures used across studies impedes researchers’ ability to compare findings. (2) Adopting Common Data Elements (CDEs) in ME/ CFS research is critical in addressing these challenges.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic, multisystem disease characterized by post-exertional malaise and persistent fatigue. The cause of ME/CFS is not well understood, and there are no established biomarkers or FDA-approved pharmacotherapies. The clinical heterogeneity of ME/CFS presents challenges to diagnosis and treatment and necessitates collaborative efforts to generate robust findings. This study leveraged gene and protein expression data from the mapMECFS data repository and the DecodeME Genome-Wide Association Study (GWAS) to assess consistent gene signatures across studies. The mitochondrial genes MT-RNR1 and MT-RNR2 exhibited lower expression in ME/CFS cases in two studies. Combining this with increased expression of mitochondrial genes in platelets from another study, this supports mitochondrial dysregulation as having a role in ME/CFS. Furthermore, ME/CFS-associated genes were mapped to compounds in drug databases as possible treatments for further investigation. In muscle gene expression data, 107 approved compounds target 26 genes with functions relevant to mitochondrial support and immunomodulators. From the DecodeME GWAS, 83 approved compounds target 24 genes with functions related to energy metabolism and mitochondrial function. Though little consistency in specific genes was observed across studies, which highlights the need for larger studies, mitochondrial dysfunction in ME/CFS cases was evident across studies.
29 September 2026 in Journal of Clinical Sleep Medicine